Table 1.
Clinical characteristics of patients with PCC/PGL.
| Baseline characteristic | n = 100 |
|---|---|
| Gender | |
| Male | 46 |
| Female | 54 |
| Age (years) | |
| <40 | 50 |
| ≥ 40 | 50 |
| Disease Site | |
| PCC monolateral | 59 |
| PCC bilateral | 5 |
| PGL (Extra-adrenal) | 36 |
| Maximum tumor diameter | |
| < 5 cm | 70 |
| ≥ 5 cm | 30 |
| Behavior | |
| Benign | 90 |
| Malignant | 10 |
| Catecholamine secretion | |
| Noradrenaline | 54 |
| Adrenaline | 28 |
| Dopamine | 15 |
| Silent | 20 |
| Missing | 13 |
| Tumor Necrosis | |
| Absent | 76 |
| Present | 16 |
| Capsular Invasion | |
| Absent | 79 |
| Present | 13 |
| Vascular Invasion | |
| Absent | 84 |
| Present | 8 |
| Genotype (germline mutations) | |
| SDH-B | 9 |
| SDH-D | 2 |
| NF-1 | 2 |
| VHL | 3 |
| RET | 12 |